Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-19 Purchase |
2024-11-20 08:30 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
2,000 | $4.99 | $9,980 | 1,506,319 (Direct) |
View |
| 2024-05-10 Purchase |
2024-05-13 08:49 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
500 | $6.29 | $3,145 | 1,504,319 (Direct) |
View |
| 2023-03-27 Purchase |
2023-03-28 08:30 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
500 | $11.55 | $5,775 | 1,373,819 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 08:31 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
670 | $15.33 | $10,273 | 1,258,319 (Direct) |
View |
| 2022-02-04 Purchase |
2022-02-08 6:01 pm |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
4,600 | $3.4422 | $15,834 | 1,197,649 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 6:12 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
150,000 | $0 | 1,656,319 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:31 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
130,000 | $0 | 1,503,819 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-13 5:05 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
115,000 | $0 | 1,373,319 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:46 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
60,000 | $0 | 1,257,649 (Direct) |
View |
Ownership |
2022-02-08 08:26 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science and Business Off |
0 | $0 | 1,193,049 (Direct) |
View |